Shilpa Medicare Ltd
Mr. Alpesh Dalal is a qualified Chartered Accountant with around 23 years of experience in diverse finance functions of corporate finance, business partnering, M&A, strategy, fund raising, controllership and investor relations. Additionally, he has cleared Registered Valuer examination for Securities or Financial Assets Class conducted by IBBI
Being a commercially astute professional, Mr. Dalal has successfully concluded 20+ M&A, fund raising, corporate restructuring & JV restructuring deals and has also worked on new business development initiatives & cost rationalisation measures during his career. He brings to table rich experience of having worked with large pharma companies like Lupin Ltd, Cipla Ltd and Wockhardt Ltd apart from diverse industry exposure with Thomas Cook (I) Ltd and Raymond Ltd.
This person is not in any offices
Shilpa Medicare Ltd
Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Specialty Chemicals. The Company supplies oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also offers AntiRetroVirals. Its non-oncology API products include Acebrophylline, Echothiophate, Nifedipine, Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid and Dimethyl Fumarate.